|
Volumn 133, Issue 5, 2000, Pages 392-393
|
Oral montelukast versus inhaled salmeterol to prevent exercise-induced bronchoconstriction [2] (multiple letters)
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALKALINE PHOSPHATASE;
BILIRUBIN;
GAMMA GLUTAMYLTRANSFERASE;
LEUKOTRIENE RECEPTOR;
MONTELUKAST;
SALMETEROL;
ZAFIRLUKAST;
ACETIC ACID DERIVATIVE;
ANTIASTHMATIC AGENT;
BRONCHODILATING AGENT;
DRUG DERIVATIVE;
QUINOLINE DERIVATIVE;
SALBUTAMOL;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
TOLUENESULFONIC ACID DERIVATIVE;
AGED;
BRONCHOSPASM;
CASE REPORT;
CORTICOSTEROID THERAPY;
DISEASE SEVERITY;
ESTROGEN THERAPY;
EXERCISE INDUCED ASTHMA;
FEMALE;
HUMAN;
LETTER;
MAINTENANCE THERAPY;
PRIORITY JOURNAL;
ECONOMICS;
MEDICAL ETHICS;
NOTE;
COMPARATIVE STUDY;
TOXIC HEPATITIS;
ACETATES;
ALBUTEROL;
ANTI-ASTHMATIC AGENTS;
ASTHMA, EXERCISE-INDUCED;
BRONCHODILATOR AGENTS;
ETHICS, MEDICAL;
HUMANS;
QUINOLINES;
AGED;
FEMALE;
HEPATITIS, TOXIC;
LEUKOTRIENE ANTAGONISTS;
TOSYL COMPOUNDS;
|
EID: 0034609590
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-133-5-200009050-00019 Document Type: Letter |
Times cited : (5)
|
References (0)
|